BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27207779)

  • 1. Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma.
    Markowitz D; Powell C; Tran NL; Berens ME; Ryken TC; Vanan M; Rosen L; He M; Sun S; Symons M; Al-Abed Y; Ruggieri R
    Mol Cancer Ther; 2016 Aug; 15(8):1799-808. PubMed ID: 27207779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer.
    Lagerweij T; Hiddingh L; Biesmans D; Crommentuijn MH; Cloos J; Li XN; Kogiso M; Tannous BA; Vandertop WP; Noske DP; Kaspers GJ; Würdinger T; Hulleman E
    Oncotarget; 2016 Jun; 7(24):35776-35788. PubMed ID: 26967057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stress kinase MRK contributes to regulation of DNA damage checkpoints through a p38gamma-independent pathway.
    Tosti E; Waldbaum L; Warshaw G; Gross EA; Ruggieri R
    J Biol Chem; 2004 Nov; 279(46):47652-60. PubMed ID: 15342622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs.
    Patties I; Kortmann RD; Menzel F; Glasow A
    J Exp Clin Cancer Res; 2016 Jun; 35(1):94. PubMed ID: 27317342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alkylphospholipid perifosine induces apoptosis and p21-mediated cell cycle arrest in medulloblastoma.
    Kumar A; Fillmore HL; Kadian R; Broaddus WC; Tye GW; Van Meter TE
    Mol Cancer Res; 2009 Nov; 7(11):1813-21. PubMed ID: 19887560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma.
    Diaz RJ; Golbourn B; Faria C; Picard D; Shih D; Raynaud D; Leadly M; MacKenzie D; Bryant M; Bebenek M; Smith CA; Taylor MD; Huang A; Rutka JT
    Oncotarget; 2015 Feb; 6(5):3359-74. PubMed ID: 25739120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide].
    Jobson AG; Lountos GT; Lorenzi PL; Llamas J; Connelly J; Cerna D; Tropea JE; Onda A; Zoppoli G; Kondapaka S; Zhang G; Caplen NJ; Cardellina JH; Yoo SS; Monks A; Self C; Waugh DS; Shoemaker RH; Pommier Y
    J Pharmacol Exp Ther; 2009 Dec; 331(3):816-26. PubMed ID: 19741151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells.
    Whiteway SL; Harris PS; Venkataraman S; Alimova I; Birks DK; Donson AM; Foreman NK; Vibhakar R
    J Neurooncol; 2013 Jan; 111(2):113-21. PubMed ID: 23138228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.
    Durant ST; Zheng L; Wang Y; Chen K; Zhang L; Zhang T; Yang Z; Riches L; Trinidad AG; Fok JHL; Hunt T; Pike KG; Wilson J; Smith A; Colclough N; Reddy VP; Sykes A; Janefeldt A; Johnström P; Varnäs K; Takano A; Ling S; Orme J; Stott J; Roberts C; Barrett I; Jones G; Roudier M; Pierce A; Allen J; Kahn J; Sule A; Karlin J; Cronin A; Chapman M; Valerie K; Illingworth R; Pass M
    Sci Adv; 2018 Jun; 4(6):eaat1719. PubMed ID: 29938225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadd45a sensitizes medulloblastoma cells to irradiation and suppresses MMP-9-mediated EMT.
    Asuthkar S; Nalla AK; Gondi CS; Dinh DH; Gujrati M; Mohanam S; Rao JS
    Neuro Oncol; 2011 Oct; 13(10):1059-73. PubMed ID: 21813510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy.
    Barker HE; Patel R; McLaughlin M; Schick U; Zaidi S; Nutting CM; Newbold KL; Bhide S; Harrington KJ
    Mol Cancer Ther; 2016 Sep; 15(9):2042-54. PubMed ID: 27422809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-1 receptor inhibition by picropodophyllin in medulloblastoma.
    Ohshima-Hosoyama S; Hosoyama T; Nelon LD; Keller C
    Biochem Biophys Res Commun; 2010 Sep; 399(4):727-32. PubMed ID: 20692232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
    Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastoma.
    Keating J; Tsoli M; Hallahan AR; Ingram WJ; Haber M; Ziegler DS
    Mol Cancer Ther; 2012 Dec; 11(12):2654-63. PubMed ID: 23012247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibition.
    Craveiro RB; Ehrhardt M; Velz J; Olschewski M; Goetz B; Pietsch T; Dilloo D
    Oncotarget; 2017 Jul; 8(29):46915-46927. PubMed ID: 28159923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RITA displays anti-tumor activity in medulloblastomas independent of TP53 status.
    Gottlieb A; Althoff K; Grunewald L; Thor T; Odersky A; Schulte M; Deubzer HE; Heukamp L; Eggert A; Schramm A; Schulte JH; Künkele A
    Oncotarget; 2017 Apr; 8(17):27882-27891. PubMed ID: 28427187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy.
    Pezuk JA; Valera ET; Delsin LE; Scrideli CA; Tone LG; Brassesco MS
    Cent Nerv Syst Agents Med Chem; 2015; 16(1):67-72. PubMed ID: 26553097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) Medulloblastoma.
    Chaturvedi NK; Kling MJ; Griggs CN; Kesherwani V; Shukla M; McIntyre EM; Ray S; Liu Y; McGuire TR; Sharp JG; Band H; Joshi SS; Coulter DW
    Mol Cancer Ther; 2020 Jun; 19(6):1351-1362. PubMed ID: 32371591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway.
    Crowther AJ; Ocasio JK; Fang F; Meidinger J; Wu J; Deal AM; Chang SX; Yuan H; Schmid R; Davis I; Gershon TR
    Cancer Res; 2016 Jun; 76(11):3211-23. PubMed ID: 27197166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.